Sugi Predict

Sugi Predict / Compounds / SCHEMBL16485709

SCHEMBL16485709

SCHEMBL16485709

c1ccc(-n2c3ccccc3c3c2ccc2c4ccc5[nH]c6ccccc6c5c4n(-c4ccccc4)c23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 2/20 0.45
▸ GABRD O14764 2/20 0.45
▸ GABRA1 P14867 2/20 0.45
▸ GABRB1 P18505 2/20 0.45
▸ GABRG2 P18507 2/20 0.45
▸ GABRB3 P28472 2/20 0.45
▸ GABRA5 P31644 2/20 0.45
▸ GABRA3 P34903 2/20 0.45
▸ GABRA2 P47869 2/20 0.45
▸ GABRB2 P47870 2/20 0.45
▸ GABRA4 P48169 2/20 0.45
▸ GABRE P78334 2/20 0.45
▸ GABRA6 Q16445 2/20 0.45
▸ GABRG1 Q8N1C3 2/20 0.45
▸ GABRG3 Q99928 2/20 0.45
▸ GABRQ Q9UN88 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ PDE7A Q13946 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12181359 0.89 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30361014 0.89 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29819565 0.89 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16484991 0.89 GABRA1 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL24991317 0.88 KDM4E (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15055965 0.87 L3MBTL1 (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29642039 0.87 L3MBTL1 (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17254120 0.87 L3MBTL1 (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16870223 0.86 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL21116952 0.85 KDM4E (0.61) L3MBTL1KDM4EATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11124521-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-09-21 — — US disclosed
US-11124521-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-09-21 — — US disclosed
US-20190315760-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-17 — — US disclosed
US-20190315760-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-17 — — US disclosed
WO-2014057685-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 (JP) 2014-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11124521-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNT1 GABRP 4642/4885GABRD 4566/4885GABRA1 3262/4885
US-20190315760-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME CCNT1, CRY1, CCNT2 GABRP 4822/4885GABRD 4629/4885GABRA1 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.